Treatments & Surgery
Share your love
Glaucoma innovation: Eight themes to watch in 2026 | Ophthalmology Times
Glaucoma care is evolving through the integration of artificial intelligence, advanced procedures, and personalized treatment strategies. (Image credit: AdobeStock/thodonal) As the ophthalmology community observes Glaucoma Awareness Month this January, glaucoma specialists point to incremental integration of technologies that support earlier…
iOpeners with Nicole Bajic, MD: Mary Qiu, MD, on tailored NVG pathways | Ophthalmology Times
With January being Glaucoma Awareness Month, it seems fitting to discuss neovascular glaucoma (NVG), a challenging and vision-threatening condition that requires thoughtful, individualized management. In this episode of iOpeners from Ophthalmology Times, host Nicole Bajic, MD, comprehensive ophthalmologist at the…
Inside the clinic: Surgeon shares real-world experience | Ophthalmology Times
(Image Credit: AdobeStock) One of the most striking results with the Light Adjustable Lens (LAL; RxSight) is how quickly patients achieve excellent vision. With traditional IOLs, vision is expected to stabilize gradually over several days as the eye heals. With…
What changed in glaucoma care in 2025: Surgeon perspective | Ophthalmology Times
In a year-end conversation, Oluwatosin U. Smith, MD, of Glaucoma Associates of Texas, in Dallas, sat down with the Eye Care Network to reflect on how glaucoma care evolved as 2025 drew to a close. Framing the discussion as a…
Global trial equity: How LMIC data is reshaping US ophthalmology research | Ophthalmology Times
Incorporating data from low- and middle-income countries may help redefine how ophthalmology trials are designed, evaluated, and applied in practice (Image credit: AdobeStock/PUTRABATARA) Innovation in ophthalmology is often measured by what reaches the clinic—but the path to those breakthroughs begins…
Achieving a new level of refractive precision: Surgical strategies | Ophthalmology Times
(Image Credit: AdobeStock) Even the most experienced cataract surgeons—armed with advanced diagnostic technologies, modern IOL power calculation formulas, and a meticulous surgical technique—encounter patients whose vision does not reach the intended refraction. A prospective analysis of about 9000 routine cataract…
FDA approvals in 2025: What changed and why it matters for ophthalmologists | Ophthalmology Times
Editor’s Note: This content was generated with the assistance of AI. From first-in-class pharmacologic therapies to next-generation retinal durability strategies and less invasive surgical platforms, 2025 emerged as a pivotal year for the ophthalmic pipeline. Over the past 12 months,…
Q&A: What changed in residency education in 2025? Perspectives from training directors | Ophthalmology Times
Residency programs are adapting to evolving training requirements, new technologies, and changing trainee needs to better prepare future ophthalmologists. (Image credit: AdobeStock/WavebreakMediaMicro) Ophthalmology residency training is constantly evolving, and 2025 marked a year of notable developments that are shaping how…
Surgeon reflection: What patient case stayed with you in 2025? | Ophthalmology Times
Neda Shamie reflects on a 2025 case that reminded her how trust, patience, and communication are as critical as any surgical technique. (Image credit: AdobeStock/LIGHTFIELD STUDIOS) As the year draws to a close, many clinicians are taking stock of the…
Molecular insights and clinical experience: Extending anti-VEGF durability | Ophthalmology Times
(Image Credit: AdobeStock) A recent Ophthalmology Times Case-Based Roundtable focused on extended anti-VEGF treatment durability. Peter K. Kaiser, MD, the Chaney Family Endowed Chair in Ophthalmology Research and professor of ophthalmology at the Cleveland Clinic Lerner College of Medicine in…